Intuit has been a monster over the last few years raising prices continuously to folks for a product that is amazingly stick, If they beat and raise firmly believe they will clip an ATH of 750 plus in short order.. down side is probably 620 range in short order if other side wins.
Earnings from LLY proved to be good on their fat drugs with concerns on tariffs for other items in their portfolio. Knowing that NVO is primary obesity with deals on the table from CVS and HIMS it is in the line of thinking that earnings will be in line with positive guidance in anticipation of market share return from these relationships. Could be wrong I am...
IMO with the new CEO and a very friendly big tech President as well as TSMC at the table and 18A project now in full swing.. shoulda would coulda I believe intel will come back to play
Send her back to $400 with haste.. magnet inbound.. elon coming back into play will help drive the business and with his name being removed from the political spotlight is a huge tail end for tsla.. folks have the memory of a hamster
NVO at long term support here, IMO one of the cheapest plays in the market, has been obliterated with BS reports etc on it being far behind meanwhile its drug profiles in the pipeline show significant strength over LLY.. this is a no brainer imo im long targets 80-100-120
